These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The development of bioactive triple helix-forming oligonucleotides. Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131 [TBL] [Abstract][Full Text] [Related]
44. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133 [TBL] [Abstract][Full Text] [Related]
45. Induction of the chromosomal translocation t(14;18) by targeting the BCL-2 locus with specific binding I-125-labeled triplex-forming oligonucleotides. Dahmen V; Schmitz S; Kriehuber R Mutat Res Genet Toxicol Environ Mutagen; 2017 Nov; 823():58-64. PubMed ID: 28985947 [TBL] [Abstract][Full Text] [Related]
46. Kinetic study of the binding of triplex-forming oligonucleotides containing partial cationic modifications to double-stranded DNA. Hari Y; Ijitsu S; Akabane-Nakata M; Yoshida T; Obika S Bioorg Med Chem Lett; 2014 Jul; 24(14):3046-9. PubMed ID: 24865415 [TBL] [Abstract][Full Text] [Related]
47. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide. Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044 [TBL] [Abstract][Full Text] [Related]
48. Exploring cellular activity of locked nucleic acid-modified triplex-forming oligonucleotides and defining its molecular basis. Brunet E; Alberti P; Perrouault L; Babu R; Wengel J; Giovannangeli C J Biol Chem; 2005 May; 280(20):20076-85. PubMed ID: 15760901 [TBL] [Abstract][Full Text] [Related]
49. Stable and Selective Antiparallel Type Triplex DNA Formation by Targeting a GC Base Pair with the TFO Containing One N Taniguchi Y; Miyazaki M; Matsueda N; Wang L; Okamura H; Sasaki S Chem Pharm Bull (Tokyo); 2018; 66(6):624-631. PubMed ID: 29863064 [TBL] [Abstract][Full Text] [Related]
50. Recognition of RNA duplexes by chemically modified triplex-forming oligonucleotides. Zhou Y; Kierzek E; Loo ZP; Antonio M; Yau YH; Chuah YW; Geifman-Shochat S; Kierzek R; Chen G Nucleic Acids Res; 2013 Jul; 41(13):6664-73. PubMed ID: 23658228 [TBL] [Abstract][Full Text] [Related]
52. Competitive binding of triplex-forming oligonucleotides in the two alternate promoters of the PMP22 gene. Hai M; Bidichandani SI; Hogan ME; Patel PI Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):233-46. PubMed ID: 11572600 [TBL] [Abstract][Full Text] [Related]
53. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides. Graham MK; Brown TR; Miller PS Biochemistry; 2015 Apr; 54(13):2270-82. PubMed ID: 25768916 [TBL] [Abstract][Full Text] [Related]
54. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Luo Z; Macris MA; Faruqi AF; Glazer PM Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9003-8. PubMed ID: 10900269 [TBL] [Abstract][Full Text] [Related]
55. Use of polyethylenimine-adenovirus complexes to examine triplex formation in intact cells. Hoque AT; Sedelnikova OA; Luu AN; Swaim WD; Panyutin IG; Baum BJ Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):229-41. PubMed ID: 10984117 [TBL] [Abstract][Full Text] [Related]
56. Selective formation of stable triplexes including a TA or a CG interrupting site with new bicyclic nucleoside analogues (WNA). Sasaki S; Taniguchi Y; Takahashi R; Senko Y; Kodama K; Nagatsugi F; Maeda M J Am Chem Soc; 2004 Jan; 126(2):516-28. PubMed ID: 14719949 [TBL] [Abstract][Full Text] [Related]
57. Design and structural analysis of hairpin-TFO for transcriptional activation of genes in S. cerevisiae. Ghosh MK; Katyal A; Brahmachari V; Chandra R J Biomol Struct Dyn; 2002 Oct; 20(2):265-73. PubMed ID: 12354078 [TBL] [Abstract][Full Text] [Related]
58. An RNA oligonucleotide corresponding to the polypyrimidine region of the rat alpha 1(I) procollagen promoter forms a stable triplex and inhibits transcription. Ririe SS; Guntaka RV Biochem Biophys Res Commun; 1998 Aug; 249(1):218-21. PubMed ID: 9705860 [TBL] [Abstract][Full Text] [Related]
59. Fluorescent intercalator displacement replacement (FIDR) assay: determination of relative thermodynamic and kinetic parameters in triplex formation--a case study using triplex-forming LNAs. Sau SP; Kumar P; Sharma PK; Hrdlicka PJ Nucleic Acids Res; 2012 Nov; 40(21):e162. PubMed ID: 22855561 [TBL] [Abstract][Full Text] [Related]